To investigate the impact of somatic mutations in homologous recombination (HR) genes on the chemotherapeutic response and survival of patients with epithelial ovarian cancer (EOC).
Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations
BENEDETTO, Chiara;CANUTO, Emilie Marion;
2016-01-01
Abstract
To investigate the impact of somatic mutations in homologous recombination (HR) genes on the chemotherapeutic response and survival of patients with epithelial ovarian cancer (EOC).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Paclitaxel is necessary for improved survival in epithelial ovarian cancers ....pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
1.53 MB
Formato
Adobe PDF
|
1.53 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
